IDXX · Full Picture

IDEXX LABORATORIES INC /DE — the full picture

Earnings window · 2026-07-14 to 2026-08-09 · anchored on the 10-Q report

One earnings window, everything merged: the filing, the call, press releases and news digests, folded into ranked threads.

What to look at first

1. Guidance / Outlook · Guidance & outlookPriority 73
   3 sources (news, press_release, transcript); 8 forward row(s); quote_verified
   Updated full year revenue outlook is $4,700 million to $4,745 million.
2. Revenue Performance and Mix · Revenue growth & mixPriority 71
   +9.1% revenue (realized); 3 sources (news, press_release, transcript); 1 forward row(s); quote_verified
   Projected CAG Diagnostics recurring revenue reported growth for 2026: 10.1% - 11.3%; projected organic growth: 9.5% - 10.7%.
3. Capital Expenditures and Cash Flow · Capital expenditurePriority 64
   3 forward row(s); quote_verified
   Company projects full year 2026 capital expenditures of approximately $180 million.
4. Geographic Market Commentary · Geographic mixPriority 62
   3 sources (news, press_release, transcript); quote_verified
   IDEXX will expand its field presence across 4 international countries during the remainder of the year, plus targeted additions in the U.S.
5. Operating Expense Trends · Operating expenses (SG&A)Priority 62
   2 sources (press_release, transcript); 1 forward row(s); quote_verified
   Operating expense for Q2 2026: $353,521, a 10% operating expense increase as reported and 9% growth on a comparable basis.
6. Free Cash Flow and Liquidity · UnclassifiedPriority 59
   2 forward row(s); quote_verified
   For the full year, IDEXX is increasing its outlook for free cash flow conversion to 90% to 100% of net income, including full year capital spending consistent at approximately $180 million.
7. Market Demand Trends · Demand, orders & backlogPriority 59
   3 sources (news, press_release, transcript); quote_verified
   Empowered Funds LLC cut its position in IDEXX by 65.7%, owning 4,172 shares after selling 7,985 shares during the quarter.
8. Capital Return Program · Buybacks & dividendsPriority 57
   2 sources (press_release, transcript); quote_verified
   IDEXX allocated $332 million to share repurchases during the second quarter and $693 million year-to-date.
9. Gross Margin Drivers · Gross marginPriority 52
   +0.8% margin; 2 sources (press_release, transcript); 2 forward row(s); quote_verified
   Updated full year reported operating margin outlook is 32.3% to 32.5%, reflecting an increased expectation of 70 to 90 basis points for full year comparable operating margin improvement.
10. FX / Currency Headwinds · Currency / FXPriority 49
    -0.6% revenue; 2 sources (press_release, transcript); 6 forward row(s); quote_verified
    The updated reported revenue outlook reflects reported revenue growth of 9.1% to 10.3%, including approximately a 60 basis point benefit to full year growth from foreign exchange at the rates outlined in the press release.
11. Income Tax Rate Changes · TaxPriority 47
    +1.3% net_income; 2 forward row(s); quote_verified
    Projected effective tax rate for 2026: ~ 21.1% (prior ~21.4%).
12. Operating Income and Margins · Operating income & profitabilityPriority 47
    +4.3% operating_income (realized); quote_verified
    Operating profit (income from operations) for Q2 2026: $425,566, up 14% year-over-year.

Threads by pillar

Revenue & Demand Priority 80 · 6 threads

• Revenue Performance and MixPriority 71 · News, Release, Call
• Geographic Market CommentaryPriority 62 · News, Release, Call
• Geographic Revenue ShiftPriority 44 · Release
• Market Demand TrendsPriority 59 · News, Release, Call
• Water And LPD DemandPriority 39 · Release
• Product Launch and TransitionPriority 46 · News, Release, Call

Costs & Margins Priority 72 · 5 threads

• Operating Expense TrendsPriority 62 · Release, Call
• Gross Margin DriversPriority 52 · Release, Call
• Operating Income and MarginsPriority 47 · Release
• Net Income and EPS PerformancePriority 46 · Release
• Diagnostic Utilization ExpansionPriority 45 · Call

Capital & Balance Sheet Priority 73 · 4 threads

• Capital Expenditures and Cash FlowPriority 64 · Release
• Capital Return ProgramPriority 57 · Release, Call
• Income Tax Rate ChangesPriority 47 · Release
• Liquidity and Debt PositionPriority 39 · Release

Strategy & Portfolio Priority 27 · 1 thread

• Acquisition / Partnership / DivestiturePriority 27 · Call

Legal, Regulatory & Policy Priority 44 · 1 thread

• Litigation and Legal RiskPriority 44 · Release

Guidance & Outlook Priority 73 · 1 thread

• Guidance / OutlookPriority 73 · News, Release, Call

Macro & Market Conditions Priority 58 · 4 threads

• FX / Currency HeadwindsPriority 49 · Release, Call
• Competition and Market SharePriority 30 · Call
• Macroeconomic Factors ImpactPriority 26 · Call
• Middle East conflict impactPriority 23 · Filing

Unclassified Priority 62 · 2 threads

• Free Cash Flow and LiquidityPriority 59 · Call
• Capital Expenditure OutlookPriority 40 · Call

Expected impact by metric